These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 6540183

  • 1. Estrone-induced, prolactin-secreting and dopamine-sensitive rat pituitary tumor.
    Lis M, Cantin M, Marchisio AM, Eljarmak D, Collu R.
    Eur J Cancer Clin Oncol; 1984 Jun; 20(6):829-39. PubMed ID: 6540183
    [Abstract] [Full Text] [Related]

  • 2. G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors.
    Bouvier C, Forget H, Lagacé G, Drews R, Sinnett D, Labuda D, Collu R.
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):33-44. PubMed ID: 1657658
    [Abstract] [Full Text] [Related]

  • 3. Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas.
    Eljarmak D, Marchisio AM, Lis M, Collu R.
    Horm Res; 1985 Jun; 21(2):107-16. PubMed ID: 3920132
    [Abstract] [Full Text] [Related]

  • 4. Effects of chronic bromocriptine treatment of an estrone-induced, prolactin-secreting rat pituitary adenoma.
    Eljarmak D, Lis M, Cantin M, Carrière PD, Collu R.
    Horm Res; 1985 Jun; 21(3):160-7. PubMed ID: 3997065
    [Abstract] [Full Text] [Related]

  • 5. Irradiation and prolactin effects on rat mammary carcinogenesis: intrasplenic pituitary and estrone capsule implants.
    Clifton KH, Yasukawa-Barnes J, Tanner MA, Haning RV.
    J Natl Cancer Inst; 1985 Jul; 75(1):167-75. PubMed ID: 3859689
    [Abstract] [Full Text] [Related]

  • 6. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
    Seo H, Refetoff S, Fang VS.
    Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
    [Abstract] [Full Text] [Related]

  • 7. Time course of induction of prolactin-secreting pituitary tumors with diethylstilbestrol in male rats: response of tuberoinfundibular dopaminergic neurons.
    Morgan WW, Steger RW, Smith MS, Bartke A, Sweeney CA.
    Endocrinology; 1985 Jan; 116(1):17-24. PubMed ID: 3917247
    [Abstract] [Full Text] [Related]

  • 8. Failure of dopamine and bromocriptine to affect prolactin release and cell growth in the dopamine receptor-deficient 235-1 clone.
    Cronin MJ, Perkins SN, Keefer DA, MacLeod RM.
    Mol Cell Endocrinol; 1982 Oct; 28(2):229-46. PubMed ID: 7128925
    [Abstract] [Full Text] [Related]

  • 9. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens.
    Drouva SV, Rerat E, Bihoreau C, Laplante E, Rasolonjanahary R, Clauser H, Kordon C.
    Endocrinology; 1988 Dec; 123(6):2762-73. PubMed ID: 2461851
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rosiglitazone, PPAR-gamma receptor ligand, decreases the viability of rat prolactin-secreting pituitary tumor cells in vitro.
    Gruszka A, Kunert-Radek J, Pawlikowski M.
    Neuro Endocrinol Lett; 2005 Feb; 26(1):51-4. PubMed ID: 15726020
    [Abstract] [Full Text] [Related]

  • 12. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
    Winneker RC, Parsons JA.
    Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effect of cabergoline, a dopamine agonist, on estrogen-induced rat pituitary tumors: in vitro culture studies.
    Eguchi K, Kawamoto K, Uozumi T, Ito A, Arita K, Kurisu K.
    Endocr J; 1995 Jun; 42(3):413-20. PubMed ID: 7670571
    [Abstract] [Full Text] [Related]

  • 15. Trifluoperazine blocks calcium-dependent action potentials and inhibits hormone release from rat pituitary tumour cells.
    Sand O, Sletholt K, Gautvik KM, Haug E.
    Eur J Pharmacol; 1982 Dec 24; 86(2):177-84. PubMed ID: 6819156
    [Abstract] [Full Text] [Related]

  • 16. Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomitant study of dopamine inhibition of GH secretion in a perifusion system.
    Bression D, Brandi AM, Nousbaum A, Le Dafniet M, Racadot J, Peillon F.
    J Clin Endocrinol Metab; 1982 Sep 24; 55(3):589-93. PubMed ID: 7096541
    [Abstract] [Full Text] [Related]

  • 17. Dopaminergic stimulation of prolactin release.
    Denef C, Manet D, Dewals R.
    Nature; 1980 May 22; 285(5762):243-6. PubMed ID: 6154895
    [Abstract] [Full Text] [Related]

  • 18. Differences in the mechanism of the inhibitory actions of catecholestrogens, tamoxifen and high concentrations of estrogens on prolactin release by cultured rat pituitary tumor cells.
    Lamberts SW, Verleun T.
    Eur J Cancer Clin Oncol; 1987 Aug 22; 23(8):1117-23. PubMed ID: 2820746
    [Abstract] [Full Text] [Related]

  • 19. Characterization of long term hormonal cell cultures from the MtT/w15 prolactin- and growth hormone-secreting rat pituitary tumor.
    McKeel DW, Hajek SA.
    Endocrinology; 1981 Apr 22; 108(4):1571-86. PubMed ID: 7472284
    [Abstract] [Full Text] [Related]

  • 20. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan 22; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.